An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers promote the drug there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.
Several professionals said the demand for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Service Reaction and Content Elimination
Based on TikTok, the platform has removed problematic content and prohibited associated keywords and search suggestions. The organization said it was committed to keeping the service safe and investing in strengthening enforcement strategies.
Online Marketplace Activities
Research also found communities with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of members, filled with images of slimming results, glowing reviews and detailed guides for preparing or injecting at residence.
After minutes of joining one group, a vendor shared WhatsApp details, where most transactions take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.
Item Details and Costs
Within these communities, messages show black plastic packages with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service stated it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has previously encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially serious health risks”.
